Nanobiotix S.A. (EPA: NANO)
France
· Delayed Price · Currency is EUR 3.202
-0.100 (-3.03%)
Dec 20, 2024, 5:35 PM CET
Nanobiotix Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Mar '21 Mar 17, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 36.22 | 30.06 | - | 0.01 | - | 0.05 | Upgrade
|
| Other Revenue | 5.98 | 6.15 | 4.78 | 2.64 | - | 2.28 | Upgrade
|
| Revenue | 42.2 | 36.21 | 4.78 | 2.65 | - | 2.33 | Upgrade
|
| Revenue Growth (YoY) | 526.17% | 658.12% | 80.43% | - | - | -8.50% | Upgrade
|
| Gross Profit | 42.2 | 36.21 | 4.78 | 2.65 | - | 2.33 | Upgrade
|
| Selling, General & Admin | 22.02 | 22.05 | 17.86 | 19.43 | - | 14.61 | Upgrade
|
| Research & Development | 42.58 | 38.4 | 32.64 | 30.38 | - | 24.33 | Upgrade
|
| Operating Expenses | 64.6 | 60.45 | 50.49 | 49.81 | - | 38.94 | Upgrade
|
| Operating Income | -22.39 | -24.24 | -45.72 | -47.17 | - | -36.62 | Upgrade
|
| Interest Expense | -8.03 | -7.98 | -5.84 | -0.67 | - | -0.33 | Upgrade
|
| Interest & Investment Income | 2.27 | 1.22 | 0.26 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.36 | -2.09 | 2.11 | 6.24 | - | -1.59 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.72 | 0 | 0 | 0.01 | - | 4.77 | Upgrade
|
| EBT Excluding Unusual Items | -25.79 | -33.09 | -49.19 | -41.58 | - | -33.77 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.23 | -4.23 | - | - | - | - | Upgrade
|
| Other Unusual Items | -3.21 | -2.26 | -7.84 | -5.41 | - | 0.19 | Upgrade
|
| Pretax Income | -33.21 | -39.58 | -57.03 | -47 | - | -33.58 | Upgrade
|
| Income Tax Expense | 0.26 | 0.12 | 0.01 | 0.01 | - | 0.01 | Upgrade
|
| Net Income | -33.47 | -39.7 | -57.04 | -47 | - | -33.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.06 | - | - | Upgrade
|
| Net Income to Common | -33.47 | -39.7 | -57.04 | -47.06 | - | -33.59 | Upgrade
|
| Shares Outstanding (Basic) | 43 | 37 | 35 | 35 | - | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 43 | 37 | 35 | 35 | - | 24 | Upgrade
|
| Shares Change (YoY) | 23.04% | 5.96% | 0.34% | - | - | 12.73% | Upgrade
|
| EPS (Basic) | -0.78 | -1.08 | -1.64 | -1.35 | - | -1.38 | Upgrade
|
| EPS (Diluted) | -0.78 | -1.08 | -1.64 | -1.35 | - | -1.38 | Upgrade
|
| Free Cash Flow | -1.53 | -12.8 | -37.2 | -30.1 | - | -27.63 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.35 | -1.07 | -0.87 | - | -1.13 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | 100.00% | Upgrade
|
| Operating Margin | -53.06% | -66.94% | -957.22% | -1781.83% | - | -1574.88% | Upgrade
|
| Profit Margin | -79.31% | -109.64% | -1194.33% | -1777.98% | - | -1444.73% | Upgrade
|
| Free Cash Flow Margin | -3.63% | -35.36% | -778.79% | -1137.14% | - | -1188.56% | Upgrade
|
| EBITDA | -22.3 | -23.69 | -45.15 | -45.61 | - | -34.86 | Upgrade
|
| EBITDA Margin | -52.83% | -65.42% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.1 | 0.55 | 0.57 | 1.56 | - | 1.75 | Upgrade
|
| EBIT | -22.39 | -24.24 | -45.72 | -47.17 | - | -36.62 | Upgrade
|
| EBIT Margin | -53.06% | -66.94% | - | - | - | - | Upgrade
|
| Revenue as Reported | 42.2 | 36.21 | 4.78 | 2.65 | - | 2.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.